Clinical Trials Directory

Trials / Completed

CompletedNCT04606628

Optimal Value Increase of Egg Products

OPTIEgg- Optimal Value Increase of Egg Products

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
57 (actual)
Sponsor
University of Oslo · Academic / Other
Sex
All
Age
70 Years – 100 Years
Healthy volunteers
Accepted

Summary

The aim of this project is to evaluate daily intake of eggshell membrane taken as supplement (capsule), will reduce markers of inflammation in older people.

Conditions

Interventions

TypeNameDescription
OTHEREggshell membrane (ESM)The intervention group will consume two capsules containing (in total) 500mg ESM with breakfast every day in 4 weeks.
OTHERPlaceboThe placebo group will consume two placebo capsules (Cellulose) with breakfast every day in 4 weeks

Timeline

Start date
2020-10-15
Primary completion
2021-10-01
Completion
2021-10-01
First posted
2020-10-28
Last updated
2022-01-21

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT04606628. Inclusion in this directory is not an endorsement.